Radisens is transforming medical diagnostics with our proprietary point-of-care device which tests for any disease, anywhere, instantly, with one drop of blood. Find out about this high growth diagnostics market, or learn more about our Gemini™ platform and breakthrough patent-pending technologies.
No other solution on the market delivers on the unmet clinical need to instantly test for any disease or medical condition at the point of care. Using a fraction of a blood drop, the Gemini™ platform offers a single device for decentralized diagnostics. Placement in physicians' offices, pharmacies or medical clinics will realize unprecedented patient access, improved outcomes and healthcare efficiencies.
Radisens' market traction and strategic partnerships is testament to our disruptive patent-pending technology, extensive intellectual property portfolio and unique value proposition.
Radisens' disruptive Gemini™ platform introduces multiple patent-pending technologies to realise a single device, which requires only a drop of patient's blood to instantly test for any disease or medical condition at the point of care with laboratory-grade results.
Integrating such a broad test menu ensures a one-stop-shop for improved patient outcomes and more efficient patient management. With all assay steps and controls integrated onto the cartridges, the clinician simply applies a finger-prick of blood, inserts the cartridge into the device, for results within minutes.